货号:A198984
同义名:
溴化新斯的明
/ Eustigmin bromide; Neoserine bromide
Neostigmine bromide 是一种可逆性乙酰胆碱酯酶抑制剂,不能通过血脑屏障,常用于重症肌无力及神经肌肉传导机制研究。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | AChE ↓ ↑ | AChR ↓ ↑ | mAChR ↓ ↑ | nAChR ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Donepezil |
+++
bAChE, IC50: 8.12 nM hAChE, IC50: 11.6 nM |
98% | |||||||||||||||||
| Loganin |
++
AChE, IC50: 3.95 μM |
99%+ | |||||||||||||||||
| topride HCl |
++
AChE, IC50: 2.04 μM |
98% | |||||||||||||||||
| Dehydroevodiamine HCl | ✔ | 99%+ | |||||||||||||||||
| Jatrorrhizine |
++
AChE, IC50: 872 nM |
99%+ | |||||||||||||||||
| Palmatine |
++
AChE, IC50: 0.51 μM |
95% | |||||||||||||||||
| (-)-Huperzine A |
++++
AChE (G4 form), Ki: 7 nM |
98% | |||||||||||||||||
| Galanthamine HBr |
++
AChE, IC50: 0.35 μM |
98% | |||||||||||||||||
| Trospium chloride | ✔ | 99% | |||||||||||||||||
| Tiotropium Bromide Monohydrate | ✔ | 97% | |||||||||||||||||
| Gallamine Triethiodide |
+
AChR, IC50: 68.0 μM |
98% | |||||||||||||||||
| Hexamethonium Bromide | ✔ | 99% | |||||||||||||||||
| Pancuronium dibromide | ✔ | 98% | |||||||||||||||||
| Neostigmine bromide | ✔ | 98% | |||||||||||||||||
| Orphenadrine citrate | ✔ | 98% | |||||||||||||||||
| Oxybutynin | ✔ | 98% | |||||||||||||||||
| Irsogladine | ✔ | PDE | 99% | ||||||||||||||||
| Pyridostigmine bromide | ✔ | 99+% | |||||||||||||||||
| Rivastigmine |
+
AChR, IC50: 5.5 μM |
98% | |||||||||||||||||
| Paroxetine HCl | ✔ | 99% | |||||||||||||||||
| Rocuronium Bromide | ✔ | 98% | |||||||||||||||||
| Tropicamide |
+++
M4 mAChR, IC50: 8 nM |
98% | |||||||||||||||||
| Diphenmanil methylsulfate | ✔ | 97% | |||||||||||||||||
| Umeclidinium bromide | ✔ | 95% | |||||||||||||||||
| Otilonium bromide | ✔ | 98% | |||||||||||||||||
| Flavoxate HCl |
+
mAChR, IC50: 12.2 μM |
99% | |||||||||||||||||
| Ipratropium bromide | ✔ | 98% | |||||||||||||||||
| Diphenidol HCl | ✔ | 98% | |||||||||||||||||
| Darifenacin hydrobromide |
++++
M3 mAChR, pKi: 8.9 |
98% | |||||||||||||||||
| Aclidinium Bromide |
++++
M2 mAChR, Ki: 0.1 nM M4 mAChR, Ki: 0.21 nM |
98% | |||||||||||||||||
| Oxybutynin chloride | ✔ | 99% | |||||||||||||||||
| Pentoxyverine citrate | ✔ | 98% | |||||||||||||||||
| Solifenacin | ✔ | 98% | |||||||||||||||||
| Catharanthine | ✔ | 98% | |||||||||||||||||
| Benzethonium chloride |
+++
α4β2 nAChRs, IC50: 49 nM α7 nAChRs, IC50: 122 nM |
99+% | |||||||||||||||||
| Vinblastine sulfate |
+
nAChR, IC50: 8.9 μM |
99% | |||||||||||||||||
| PNU-120596 |
++
α7 nAChR, EC50: 216 nM |
99+% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Neostigmine bromide is a reversible acetylcholine esterase inhibitor that binds to the anionic binding site of AChE. Administration of neostigmine, may successfully reverse some negative effects of inflammation on the GnRH (gonadotropin-releasing hormone) neurons[3]. As the molecular weight of neostigmine bromide is 303 g/mol and the steady-state volume of distribution is approximately 0.5 L/kg, its plasma concentration was calculated to be 0.13–0.46 μM. The dosage of neostigmine can be reduced properly when used to antagonize the residual neuromuscular block in septic patients[4]. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03399890 | - | Completed | - | Turkey ... 展开 >> Ankara University Faculty of Medicine Ankara, Turkey 收起 << | |
| NCT03519633 | Curarization, Postoperative Re... 展开 >>sidual 收起 << | Phase 2 | Not yet recruiting | January 30, 2019 | Italy ... 展开 >> Campus Bio-medico Recruiting Roma, RM, Italy, 00128 Contact: Corrado Terranova 06225411203 ext +39 c.terranova@unicampus.it 收起 << |
| NCT03519724 | Curarization, Postoperative Re... 展开 >>sidual 收起 << | Phase 2 | Not yet recruiting | January 30, 2019 | Italy ... 展开 >> Campus Bio-medico Recruiting Roma, RM, Italy, 00128 Contact: Corrado Terranova 06225411203 ext +39 c.terranova@unicampus.it 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.30mL 0.66mL 0.33mL |
16.49mL 3.30mL 1.65mL |
32.98mL 6.60mL 3.30mL |
|
| CAS号 | 114-80-7 |
| 分子式 | C12H19BrN2O2 |
| 分子量 | 303.2 |
| SMILES Code | C[N+](C)(C)C1=CC=CC(OC(N(C)C)=O)=C1.[Br-] |
| MDL No. | MFCD00011795 |
| 别名 | 溴化新斯的明 ;Eustigmin bromide; Neoserine bromide |
| 运输 | 蓝冰 |
| InChI Key | LULNWZDBKTWDGK-UHFFFAOYSA-M |
| Pubchem ID | 8246 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
| 溶解方案 |
DMSO: 105 mg/mL(346.31 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(329.82 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1